These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38535549)

  • 1. Genomic Insights into
    Gómez-Casanova N; Gutiérrez-Zufiaurre MN; Blázquez de Castro AM; Muñoz-Bellido JL
    Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
    Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
    Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
    Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
    Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.
    Berti AD; Baines SL; Howden BP; Sakoulas G; Nizet V; Proctor RA; Rose WE
    Antimicrob Agents Chemother; 2015 May; 59(5):2799-806. PubMed ID: 25733508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin Resistant
    Sabat AJ; Tinelli M; Grundmann H; Akkerboom V; Monaco M; Del Grosso M; Errico G; Pantosti A; Friedrich AW
    Front Microbiol; 2018; 9():2705. PubMed ID: 30459746
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
    Friedman L; Alder JD; Silverman JA
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2137-45. PubMed ID: 16723576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of
    Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
    Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
    Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
    Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
    Rubio A; Conrad M; Haselbeck RJ; G C K; Brown-Driver V; Finn J; Silverman JA
    Antimicrob Agents Chemother; 2011 Jan; 55(1):364-7. PubMed ID: 20974866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
    Bæk KT; Thøgersen L; Mogenssen RG; Mellergaard M; Thomsen LE; Petersen A; Skov S; Cameron DR; Peleg AY; Frees D
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6983-91. PubMed ID: 26324273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Laboratory Evolution of
    Gostev V; Kalinogorskaya O; Sopova J; Sulian O; Chulkova P; Velizhanina M; Tsvetkova I; Ageevets I; Ageevets V; Sidorenko S
    Antibiotics (Basel); 2023 May; 12(5):. PubMed ID: 37237831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
    Rose WE; Fallon M; Moran JJ; Vanderloo JP
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4422-7. PubMed ID: 22687502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
    Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.